Metformin Offers No Survival Boost in Metastatic Prostate Cancer

(Medage today) – An antidiabetic pillar has not provided additional survival benefit to patients with cancer of the metastatic prostate sensitive to hormones, according to the results of a phase III test. In Stampede, overall survival was not statistically …